Kamaal Anas

Kamaal Anas has a diverse work experience in regulatory affairs and quality assurance, holding various leadership positions in several companies. Kamaal is currently the Corporate Vice President of Regulatory Affairs at B. Braun Group and previously served as the Vice President of Regulatory Affairs and Quality at Aesculap. Prior to that, they had roles as the Vice President of Regulatory Affairs at MicroPort Orthopedics Inc. and the Senior Director of Regulatory Affairs and Quality Assurance at the International AIDS Vaccine Initiative (IAVI). Kamaal also held leadership positions at Meridian Life Science, Inc. and Equi-Tox, Inc. throughout their career.

Kamaal Anas has a Bachelor of Science degree in Biology from Furman University and a Master of Science degree in Nutrition from Clemson University. Kamaal also holds a certificate in the International Executive MBA Residency Program from Grenoble Ecole de Management. Kamaal has completed an Executive MBA program in Business Administration/Management from The University of Memphis. Additionally, they have obtained certifications including the RAC-US from the Regulatory Affairs Certification Program and the Regulatory Affairs Certified (RAC) from the Regulatory Affairs Professionals Society (RAPS).